West Paces Advisors Inc. Baxter International Inc Transaction History

West Paces Advisors Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 18, 2023	SELL	$39.98 - $47.68 $5,996 - $7,152	-150 Closed	0 $0
Q4 2022 Dec 18, 2023	BUY	$49.7 - $57.71 $7,455 - $8,656	150 New	150 $7.65 Million
Q1 2022 Dec 18, 2023	BUY	$76.85 - $89.45 $13,525 - $15,743	176 New	176 $13.6 Million
Q4 2021 Dec 19, 2023	SELL	$74.57 - $87.19 $5,443 - $6,364	-73 Reduced 29.32%	176 $15.1 Million
Q1 2021 Dec 19, 2023	SELL	$76.38 - $86.03 $9,929 - $11,183	-130 Reduced 34.3%	249 $21 Million
Q2 2020 Dec 19, 2023	BUY	$78.66 - $94.14 $29,812 - $35,679	379 New	379 $32.6 Million
Q1 2020 Dec 20, 2023	BUY	$71.57 - $93.3 $5,296 - $6,904	74 Added 24.26%	379 $30.8 Million
Q3 2019 Dec 21, 2023	BUY	$81.4 - $89.78 $10,582 - $11,671	130 Added 42.62%	435 $38 Million
Q3 2018 Dec 20, 2023	BUY	$70.71 - $77.75 $21,566 - $23,713	305 New	305 $23.5 Million
Q3 2017 Dec 21, 2023	SELL	$59.5 - $64.61 $128,044 - $139,040	-2,152 Reduced 87.59%	305 $19.1 Million
Q1 2017 Dec 21, 2023	SELL	N/A	-472 Reduced 16.11%	2,457 $127 Million
Q4 2016 Dec 21, 2023	BUY	N/A	2,929	2,929 $130 Million

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on West Paces Advisors Inc. with notifications on news.